A Rising Star In The Already Bright Firmament Of Neuroscience

Thanks to advances in molecular biology, genetics, imaging tools, and computer power, neuroscience research is growing ever more subtle in detail, as witness the increased attention being paid by researchers to various aspects of neurotoxicity - particularly the role of excitatory amino acid neurotransmitters in controlling the impact of signals on the brain. Some neuroscience researchers specializing in this area have been focusing their attention on the interaction of proteins such as NMDA (

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Some neuroscience researchers specializing in this area have been focusing their attention on the interaction of proteins such as NMDA (N-methyl-d-aspartate) receptors, glutamate receptors, and quisqualate receptors in an effort to determine the extent to which the interaction determines the activation of short- and long-term memory.

In their explorations, the researchers hope to understand one of the most important pathways of the brain - a pathway that appears to play a major role not only in memory, but also in the pathogenesis of various neurologic diseases.

The accompanying chart - based on the Institute for Scientific Infor- mation's 1987 Research Front database - demonstrates the dramatic emergence of "excitatory amino acids" as a particularly fast-developing field within the general area of neurotoxicity.

A "research front" is a specialty area containing a group of intellectually related papers published in a given year (here, 1987) as well the earlier - or ~~"core" ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies